DIAGNOS (CVE:ADK) Hits New 52-Week High – What’s Next?

DIAGNOS Inc. (CVE:ADK)’s share price hit a new 52-week high on Wednesday . The company traded as high as C$0.45 and last traded at C$0.44, with a volume of 236448 shares. The stock had previously closed at C$0.41.

DIAGNOS Stock Performance

The firm has a market cap of C$59.00 million, a PE ratio of -12.25 and a beta of -0.14. The company has a debt-to-equity ratio of 204.05, a current ratio of 1.49 and a quick ratio of 0.68. The stock has a 50-day moving average price of C$0.30 and a 200 day moving average price of C$0.27.

Insider Transactions at DIAGNOS

In other DIAGNOS news, Director Robert Dunn purchased 200,000 shares of the stock in a transaction on Wednesday, July 29th. The stock was bought at an average price of C$0.30 per share, for a total transaction of C$60,000.00. Following the acquisition, the director directly owned 2,117,778 shares of the company’s stock, valued at C$635,333.40. This represents a 10.43% increase in their ownership of the stock. Over the last quarter, insiders bought 328,571 shares of company stock valued at $96,000. 16.81% of the stock is currently owned by company insiders.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.